
Sign up to save your podcasts
Or


Ketamine has gone from a recreational psychedelic to an approved treatment, and it has caught on in Silicon Valley in a big way. Are the long-term effects of using ketamine—recreationally or therapeutically—sufficiently known? Are we witnessing them right now?
Guest: Shayla Love, staff writer for the Atlantic.
Want more What Next TBD? Subscribe to Slate Plus to access ad-free listening to the whole What Next family and all your favorite Slate podcasts. Subscribe today on Apple Podcasts by clicking “Try Free” at the top of our show page. Sign up now at slate.com/whatnextplus to get access wherever you listen.
Learn more about your ad choices. Visit megaphone.fm/adchoices
By Slate Podcasts4.5
547547 ratings
Ketamine has gone from a recreational psychedelic to an approved treatment, and it has caught on in Silicon Valley in a big way. Are the long-term effects of using ketamine—recreationally or therapeutically—sufficiently known? Are we witnessing them right now?
Guest: Shayla Love, staff writer for the Atlantic.
Want more What Next TBD? Subscribe to Slate Plus to access ad-free listening to the whole What Next family and all your favorite Slate podcasts. Subscribe today on Apple Podcasts by clicking “Try Free” at the top of our show page. Sign up now at slate.com/whatnextplus to get access wherever you listen.
Learn more about your ad choices. Visit megaphone.fm/adchoices

31,989 Listeners

30,706 Listeners

10,725 Listeners

1,378 Listeners

1,023 Listeners

2,844 Listeners

996 Listeners

1,028 Listeners

7,687 Listeners

5,632 Listeners

1,026 Listeners

6,291 Listeners

1,873 Listeners

2,542 Listeners

4,004 Listeners

53 Listeners

2,069 Listeners

237 Listeners

23,888 Listeners

9,532 Listeners

1,284 Listeners

16,335 Listeners

824 Listeners

1,195 Listeners

436 Listeners

15,832 Listeners

60 Listeners

1,670 Listeners

48 Listeners

97 Listeners

7 Listeners

130 Listeners